In a study of 8,820 men with metastatic castration-resistant prostate cancer, researchers found the prognosis differs substantially based on where the cancer has spread.
Spread to the liver is associated with shorter survival than lung and bone spread, and patients with lymph node metastases only have the best overall survival.
Read the article.